KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Emergent BioSolutions (EBS) Current Leases: 2010

Emergent BioSolutions' Current Leases was N/A to $17.0 million in Q4 2010 from the same period last year, while for Dec 2010 it was $17.0 million, marking a year-over-year change of. This contributed to the annual value of $17.0 million for FY2010, which is N/A change from last year.
As of Q4 2010, Emergent BioSolutions' Current Leases stood at $17.0 million.
Emergent BioSolutions' Current Leases' 5-year high stood at $17.0 million during Q4 2010, with a 5-year trough of $17.0 million in Q4 2010.
Over the past 1 years, Emergent BioSolutions' median Current Leases value was $17.0 million (recorded in 2010), while the average stood at $17.0 million.